Effect of Id1 knockdown on formation of osteolytic bone lesions by prostate cancer PC3 cells in vivo

Abstract

The formation of osteolytic bone lesions is a key process for osteolytic cancer to metastasize to the bone and is under the control of a set of transcription factors. Recently, the inhibitor of differentiation 1 (Id1) has been linked with angiogenesis, tumorigenesis, metastasis and bone formation. However, the function of Id1 during the process of bone destruction caused by cancer in vivo has not yet been elucidated. We, therefore, examined whether and how Id1 affects the ability of cancer to form osteolytic lesion in vivo. The study used a lentiviral vector overexpressing short hairpin RNA (shRNA) targeting Id1 gene. PC3 cells, a prostate cancer cell line, were transduced with Id1 shRNA or negative control (NC) shRNA before implantation in BALB/c mice. Cells were implanted in a tibial injection model. Tumor formation in bone was monitored by X-ray. The relationship between parathyroid hormone-related protein (PTHrP), an osteolytic factor, and Id1 was analyzed by using immunohistochemistry in tissue sections from osteolytic lesion of the BALB/c mice. Our results showed that Id1 shRNA delivery to PC3 cells by lentivirus caused efficient and stable Id1 gene silencing. In the intratibial model, PC3 cells produced primarily osteolytic lesions in the bone. Eleven of 14 mice in Id1 shRNA group but only 4 of 14 mice in the NC shRNA group developed osteolytic lesions with cortical destruction at 4th week. Mice treated with Id1 shRNA had larger tumor volume in the bone and larger cortical destruction. The expression of PTHrP protein in PC3 cells was not affected by Id1 knockdown in vivo. These results indicate that Id1 may down-regulate the ability of PC3 cells to form osteolytic lesions in vivo and the signal pathway needs to be further investigated.

Keywords

inhibitor of differentiation 1 / bone metastasis / prostate cancer

References

[1] SunX.H., CopelandN.G., JenkinsN.A., et al.. Id proteins Id1 and Id2 selectively inhibit DNA binding by one class of helix-loop-helixproteins. Mol Cell Biol, 1991, 11(11): 5603-5611

[2] O’TooleP.J., InoueT., EmersonL., et al.. Id proteins negatively regulate basic helix-loop-helix transcription factor function by disrupting subnuclear compartmentalization. J Biol Chem, 2003, 278(46): 45 770-45 776

[3] NortonJ.D.. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci, 2000, 113(Pt22): 3897-3905

[4] YingQ.L., NicholsJ., ChambersI., et al.. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell, 2003, 115(3): 281-292

[5] MaedaY., TsujiK., NifujiA., et al.. Inhibitory helix-loop-helix transcription factors Id1/Id3 promote bone formation in vivo. J Cell Biochem, 2004, 93(2): 337-344

[6] LeeJ., KimK., KimJ.H., et al.. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood, 2006, 107(7): 2686-2693

[7] BenezraR., RafiiS., LydenD.. The Id proteins and angiogenesis. Oncogene, 2001, 20(58): 8334-8341

[8] SakuraiD., TsuchiyaN., YamaguchiA., et al.. Crucial role of inhibitor of DNA binding/differentiation in the vascular endothelial growth factor-induced activation and angiogenic processes of human endothelial cells. J Immunol, 2004, 173(9): 5801-5909

[9] VolpertO.V., PiliR., SikderH.A., et al.. Id1 regulates angiogenesis through transcriptional repression of thrombospondin-1. Cancer Cell, 2002, 2(6): 473-483

[10] FongS., DebsR.J., DesprezP.Y.. Id genes and proteins as promising targets in cancer therapy. Trends Mol Med, 2004, 10(8): 387-392

[11] LuanY., YuX.P., YangN., et al.. p204 protein overcomes the inhibition of core binding factor alpha-1-mediate dosteogenic differentiation by Id helix-loop-helix proteins. Mol Biol Cell, 2008, 19(5): 2113-2126

[12] OuyangX., WangX., LingM., et al.. Id-1 stimulates serum independent prostate cancer cell proliferation through inactivation of p16(INK4a)/pRB pathway. Carcinogenesis, 2002, 23(5): 721-725

[13] LingM., WangX., OuyangX., et al.. Id-1 expression promotes cell survival through activation of NF-kappaB signaling pathway in prostate cancer cells. Oncogene, 2003, 22(29): 4498-4508

[14] LingM., LauT., ZhouC., et al.. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF). Carcinogenesis, 2005, 26(10): 1668-1676

[15] ZhangX., LingM., WangQ., et al.. Identification of a novel inhibitor of differentiation-1 (ID-1) binding partner, caveolin-1, and its role in epithelial-mesenchymal transition and resistance to apoptosis in prostate cancer cells. J Biol Chem, 2007, 282(46): 33 284-33 294

[16] BubendorfL., SchöpferA., WagnerU., et al.. Metastatic patterns of prostate cancer: an autopsy study of 1, 589 patients. Hum Pathol, 2000, 31(5): 578-583

[17] JemalA., SiegelR., WardE., et al.. Cancer statistics, 2009. CA Cancer J Clin, 2009, 59(4): 225-249

[18] WeilbaecherK.N., GuiseT.A., McCauleyL.K.. Cancer to bone: a fatal attraction. Nat Rev Cancer, 2011, 11(6): 411-425

[19] YinJ.J., PollockC.B., KellyK.. Mechanisms of cancer metastasis to the bone. Cell Res, 2005, 15(1): 57-62

[20] YonedaT., HiragaT.. Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Bioph Res Co, 2005, 328(3): 679-687

[21] ChenY.C., SosnoskiD.M., MastroA.M.. Breast cancer metastasis to the bone: mechanisms of bone loss. Breast Cancer Res, 2010, 12(6): 215

[22] TakayamaY., MoriT., NomuraT., et al.. Parathyroid-related protein plays a critical role in bone invasion by oral squamous cell carcinoma. Int J Oncol, 2010, 36(6): 1387-1394

[23] GautschiO., TepperC.G., PurnellP.R., et al.. Regulation of Id1 expression by SRC: implications for targeting of the bone morphogenetic protein pathway in cancer. Cancer Res, 2008, 68(7): 2250-2258

[24] DuY., XiaoQ., YipH.K.. Regulation of retinal progenitor cell differentiation by bone morphogenetic protein 4 is mediated by the smad/id cascade. Invest Ophthalmol Vis Sci, 2010, 51(7): 3764-3773

[25] KangY., ChenC.R., MassaguéJ.. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol Cell, 2003, 11(4): 915-926

[26] GoumansM.J., ValdimarsdottirG., ItohS., et al.. Activin receptor-like kinase^(ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5signaling. Mol Cell, 2003, 12(4): 817-828

[27] ZhangX., LiJ., NieJ., et al.. Differentiation character of adult mesenchymal stem cells and transfection of MSCs with lentiviral vectors. J Huazhong Univ Sci Technol [Med Sci], 2010, 30(6): 687-693

[28] ZhangY.H., WuQ., XiaoX.Y., et al.. Silencing MRP4 by small interfering RNA reverses acquired DDP resistance of gastric cancer cell. Cancer Lett, 2010, 291(1): 76-82

[29] AnD.S., XieY., MaoS.H., et al.. Efficient lentiviral vectors for short hairpin RNA delivery into human cells. Hum Gene Ther, 2003, 14(12): 1207-1212

[30] ZhengM., SunH., ZhouJ., et al.. Proliferation and apoptosis of bone marrow CD4(+) T cells in patients with aplasticanemia and impacts of the secreted cytokines on hematopoietic stem cells from umbilical cord blood. J Huazhong Univ Sci Technol [Med Sci], 2010, 30(1): 37-41

[31] ChenX., JiaoZ., WangL., et al.. Roles of human epicardial adipose tissue in coronary artery atherosclerosis. J Huazhong Univ Sci Technol [Med Sci], 2010, 30(5): 589-593

[32] PratapJ., WixtedJ.J., GaurT., et al.. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells. Cancer Res, 2008, 68(19): 7795-7802

[33] JohnsonR.W., NguyenM.P., PadaleckiS.S., et al.. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res, 2011, 71(3): 822-831

[34] LiaoJ., McCauleyL.K.. Skeletal metastasis: Established and emerging roles of parathyroid hormone related protein (PTHrP). Cancer Metastasis Rev, 2006, 25(4): 559-571

[35] ChanA.S., JensenK.K., SkokosD., et al.. Id1 represses osteoclast-dependent transcription and affects bone formation and hematopoiesis. PLoS One, 2009, 4(11): e7955

[36] WongY.C., WangX., LingM.T.. Id-1 expression and cell survival. Apoptosis, 2004, 9(3): 279-289

[37] LeeT.K., PoonR.T., YuenA.P., et al.. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma. Clin Cancer Res, 2006, 12(23): 6910-6919

[38] YuenH.F., ChiuY.T., ChanK.K., et al.. Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1. Br J Cancer, 2010, 102(2): 332-341

[39] GuptaG.P., PerkJ., AcharyyaS., et al.. ID genes mediate tumor reinitiation during breast cancer lung metastasis. Proc Natl Acad Sci USA, 2007, 104(49): 19 506-19 511